Date: 21 September 2017
Here’s some highlights from the third week of our World Alzheimer’s Month campaign - our focus has been how patients can get access to new dementia treatments.
With World Alzheimer’s Day taking place on 21 September, researchers from the NIHR Cambridge Biomedical Research Centre (BRC) highlighted how they’re working to find new treatments to reduce the effects of Alzheimer’s disease - Professor John O’Brien explains here.
ENGAGE is an international study looking to determine whether a new medication called Aducanumab can slow the progression of early Alzheimer’s. Researchers are currently looking for volunteers aged 50-85 and recruitment of participants is being supported by Join Dementia Research.
Colin was diagnosed with Posterior Cortical Atrophy (PCA) which is a rare form of dementia and he has taken part in a number of research studies. He talks about his journey in this video.
When Hilary Doxford was diagnosed with early onset Alzheimer’s disease she saw no light at the end of the tunnel, but she soon realised she could take some control and began to investigate dementia research. Hilary’s search led to her the NIHR, find out what this meant for her, here.
Dementia research takes a variety of forms and just like Hilary and Colin you can find what works for you. Cutting-edge research is taking place to see if new and existing drugs could help to slow down dementia and possibly hold the key to a cure - find out if you could be eligible to take part.
You can keep updated on the campaign here.
You may also be interested in